UNITED
STATES
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported)
Bovie
Medical Corporation
(Exact
name of registrant as specified in its charter)
|
Delaware |
|
11-2644611 |
|
(State
or other jurisdiction |
(Commission |
(IRS
Employer |
|
Of
incorporation) |
File
Number) |
Identification
No.) |
734 Walt
Whitman Road, Melville, New York
11747
(Address
of principal executive offices) (Zip
Code)
Registrant's
telephone number, including area code
(631)
421-5452
N/A
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act 17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule l4a-12 under the Exchange Act (17 CFR
240.l4a-12)
[ ]
Pre-commencement communications pursuant to Rule l4d- 2(b) under the Exchange
Act (17 CFR
240. l4d- 2(b)
[ ]
Pre-commencement communications pursuant to Rule 13 e-4( c) under the Exchange
Act (17 CFR
240.13 e-4( c)
SEE
ATTACHED EXHIBIT
EXHIBITS:
Press
release January 12, 2006 announcing acquisition of endoscopic modular instrument
technology
BOVIE
MEDICAL CORPORATION
By:/S/ANDREW
MAKRIDES
ANDREW
MAKRIDES
PRESIDENT
